Andreas Argyrides Profile - Oppenheimer Analyst

242 Followers
tipranks
Andreas Argyrides

Andreas Argyrides
Oppenheimer

Wall Street Analyst
#1,115 out of 10,109 Wall Street Analysts
#2,948 out of 42,308 experts

Success Rate

47%
123 out of 264 ratings made a profit

Average Return

+13.10%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Andreas Argyrides's trades since 2022 and holding each position for 1 Year would result in 46.59% of your transactions generating a profit, with an average return of 13.1% per rating.

Stock Rating Distribution

415Ratings
78.31% Buy
18.55% Hold
3.13% Sell
Distribution of Andreas Argyrides's ratings

Additional Information

Main Sector:General
Geo Coverage:
United States

Best Rating

Stock:
Aquestive Therapeutics, Inc.
(AQST)
Rating:Buy
Date:Mar 09, 2023 - Mar 09, 2024
Return:+502.40%
The most profitable rating made by Andreas Argyrides

Andreas Argyrides's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
GBT
Global Blood Therapeutics
Aug 08, 2022
Hold
Downgraded
5Ratings
100%
+136.37%
CalciMedica
Aug 25, 2022
Hold
Assigned
6Ratings
0.00%
ALBO
Albireo Pharma
Mar 02, 2023
Hold
Reiterated
13Ratings
100%
+96.98%
UNBX
Unity Biotechnology
Nov 16, 2023
Buy
Upgraded
$4.00
(7030.12% Upside)
21Ratings
20%
-35.49%
Ascendis Pharma
Feb 08, 2024
Buy
Assigned
$225.00
(8.99% Upside)
30Ratings
57%
+16.28%
Immunic
Feb 22, 2024
Buy
Reiterated
$4.00
(461.40% Upside)
11Ratings
33%
-18.26%
BioMarin Pharmaceutical
Feb 23, 2024
Hold
Reiterated
$80.00
(47.55% Upside)
22Ratings
0.00%
Pacira Pharmaceuticals
Mar 01, 2024
Buy
Reiterated
$57.00
(141.32% Upside)
8Ratings
0%
-30.95%
VRNA
Verona Pharma
Mar 01, 2024
Buy
Assigned
$33.00
(-69.13% Downside)
17Ratings
69%
+53.53%
RegenXBio
Mar 05, 2024
Hold
Reiterated
$21.00
(80.41% Upside)
25Ratings
0.00%
List of latest recommendations made by Andreas Argyrides. Click to expand and see Andreas Argyrides's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Andreas Argyrides activity FAQ

What is the performance of Andreas Argyrides's recommendations?
The percentage of profitable recommendations made by Andreas Argyrides is 47%, and the average return per transaction is 13.10%.
    What stocks does Andreas Argyrides cover?
    Andreas Argyrides mostly covers ASND ,MLTX ,RGNX stocks.
      What was Andreas Argyrides's most profitable rating?
      Andreas Argyrides’s most profitable ratings was a buy on AQST stock on Mar 09, 2023 - Mar 09, 2024. The return on the trade was +502.40%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here